文献速递临床生化质量管理与危急值

北欧溶血项目:临床化学实验室对溶血血清样本的处理

Handling of hemolyzed serum samples in clinical chemistry laboratories: the Nordic hemolysis project.
PubMed 文献 · Clin Chem Lab Med · 2019-01-01

北欧溶血项目向145家实验室分发4份不同溶血程度的相同样本,要求检测游离血红蛋白及15项临床化学分析物并填写问卷。63%实验室使用自动化溶血检测,88%有书面处理程序;多数分析物受溶血干扰程度在各仪器平台间一致,但碱性磷酸酶、总胆红素和肌酸激酶例外;厂家推荐的拒收截断值差异大,实验室间报告方式差异大。

要点

  • 多数临床化学分析物受溶血干扰程度在不同仪器平台间一致。
  • 碱性磷酸酶、总胆红素和肌酸激酶受溶血干扰因仪器平台而异。
  • 厂家推荐的溶血样本结果拒收截断值差异大,实验室报告方式不一。

核心结论

  • 多数分析物受溶血影响程度在不同仪器间一致,但实验室间对溶血样本结果的报告方式差异大,即使使用相同仪器类型。

研究设计与样本

  • 向北欧国家145家实验室分发4份含不同溶血程度的相同样本,要求检测游离血红蛋白和15项临床化学分析物,并填写溶血样本处理与报告问卷。

主要发现

  • 63%的实验室对所有常规患者样本使用自动化溶血检测,88%有书面处理溶血样本的程序。
  • 不同仪器平台测得的4份样本平均血红蛋白浓度可比。
  • 多数分析物受溶血干扰程度在各仪器平台间一致,但碱性磷酸酶、总胆红素和肌酸激酶例外。
  • 厂家推荐的拒收结果截断值差异大,实验室报告方式不一,即使使用相同仪器类型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background Some clinical chemistry measurement methods are vulnerable to interference if hemolyzed serum samples are used. The aims of this study were: (1) to obtain updated information about how hemolysis affects clinical chemistry test results on different instrument platforms used in Nordic laboratories, and (2) to obtain data on how test results from hemolyzed samples are reported in Nordic laboratories. Methods Four identical samples containing different degrees of hemolysis were prepared and distributed to 145 laboratories in the Nordic countries. The laboratories were asked to measure the concentration of cell-free hemoglobin (Hb), together with 15 clinical chemistry analytes. In addition, the laboratories completed a questionnaire about how hemolyzed samples are handled and reported. Results Automated detection of hemolysis in all routine patient samples was used by 63% of laboratories, and 88% had written procedures on how to handle hemolyzed samples. The different instrument platforms measured comparable mean Hb concentrations in the four samples. For most analytes, hemolysis caused a homogenous degree of interference regardless of the instrument platform used, except for alkaline phosphatase (ALP), bilirubin (total) and creatine kinase (CK). The recommended cut-off points for rejection of a result varied substantially between the manufacturers. The laboratories differed in how they reported test results, even when they used the same type of instrument. Conclusions Most of the analytes were homogeneously affected by hemolysis, regardless of the instrument used. There is large variation, however, between the laboratories on how they report test results from hemolyzed samples, even when they use the same type of instrument.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Gidske G, Aakre KM, Rustad P, et al. Handling of hemolyzed serum samples in clinical chemistry laboratories: the Nordic hemolysis project. Clin Chem Lab Med. 2019. PMID: 31617690. doi:10.1515/cclm-2019-0366

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。